VECT NASDAQ
VectivBio Holding AG
1W: -0.4%
1M: +1.5%
3M: +93.7%
1Y: +182.7%
$16.87
Last traded 2023-07-07 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Income Trends
Revenue
$27M
+0.0% ▲
Gross Profit
$27M
+0.0% ▲
Operating Income
-$81M
+7.1% ▲
Net Income
-$94M
-7.7% ▼
EPS (Diluted)
$-2.12
+34.4% ▲
EBITDA
-$80M
+7.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $27M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $27M |
| Gross Margin | — | — | — | 100.0% |
| R&D Expenses | $16M | $43M | $50M | $74M |
| SG&A Expenses | $8M | $14M | $36M | $34M |
| Operating Expenses | $24M | $57M | $87M | $108M |
| Operating Income | -$24M | -$57M | -$87M | -$81M |
| Operating Margin | — | — | — | -294.5% |
| Interest Expense | $50K | $554K | $36K | $3M |
| Income Before Tax | -$23M | -$60M | -$87M | -$94M |
| Tax Expense | $50K | $554K | $64K | $107K |
| Net Income | -$24M | -$60M | -$87M | -$94M |
| Net Margin | — | — | — | -342.8% |
| EPS (Diluted) | $-1.01 | $-2.40 | $-3.23 | $-2.12 |
| EBITDA | -$23M | -$58M | -$86M | -$80M |
| Shares Outstanding | 23M | 25M | 27M | 44M |